The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.83BCNY
1.02B · vs all stocks (USD)
Updated Sep 21, 2026
Revenue (TTM)
391.11MCNY
58.36M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
-10.62%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Beta
0.5000x
vs all stocks
Updated Sep 21, 2026
52-Week Change
80.39%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
6.83BCNY
1.02B · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
6.73BCNY
1.00B · vs all stocks (USD)
Updated Sep 21, 2026
Price to Sales (TTM)
17.45x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Price to Book (MRQ)
11.16x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Enterprise to Revenue
17.21x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Gross Margin
36.13%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 23.78%.Updated Sep 21, 2026
Profit Margin
-10.62%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Operating Margin
2.78%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Return on Assets (TTM)
-1.07%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Return on Equity (TTM)
-5.36%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Revenue (TTM)
391.11MCNY
58.36M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
3.34CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
29.90%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Gross Profit (TTM)
93.00MCNY
13.88M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
5.31MCNY
792.50K · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
-41.55MCNY
-6.20M · vs all stocks (USD)
Updated Sep 21, 2026
Quarterly Earnings Growth (YoY)
0.24%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Operating Cash Flow (TTM)
-15.27MCNY
-2.28M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
-56.70MCNY
-8.46M · vs all stocks (USD)
Updated Sep 21, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Minority Interest (Equity)
7.86MCNYFY2025 · Dec 31, 2025
Revenue
398.36MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
317.42MCNYFY2025 · Dec 31, 2025
Gross Profit
80.94MCNYFY2025 · Dec 31, 2025
Operating Income
-36.05MCNY
-5.38M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-51.23MCNYFY2025 · Dec 31, 2025
Income Tax Expense
10.53MCNYFY2025 · Dec 31, 2025
Net Income
-61.75MCNYFY2025 · Dec 31, 2025
EBIT
-49.59MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-7.75MCNYFY2025 · Dec 31, 2025
Research & Development
27.08MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
41.06MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
1.54MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
813.06KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.64MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.5800CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.5800CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
117.24MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
117.24MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-61.75MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-6.25MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-13.01MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-69.08MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
181.08MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-61.75MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
18.56MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-9.16MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
39.35MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-56.07MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-22.49MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.28BCNYFY2025 · Dec 31, 2025
Sale of Investments
1.31BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-60.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-108.87MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
98.24MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-86.67MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-1.60MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-73.22MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-63.25MCNYFY2025 · Dec 31, 2025
Shares Outstanding
120.00MSharesUpdated Sep 21, 2026
Float Shares
70.62MSharesUpdated Sep 21, 2026
% Held by Insiders
48.67%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
11.09%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
144.69MCNY
21.59M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
1.22CNYUpdated Sep 21, 2026
Total Debt (MRQ)
145.38MCNY
21.69M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
0.2378x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Current Ratio (MRQ)
1.91x
vs Scientific & Technical Instruments peers
Updated Sep 21, 2026
Book Value per Share (MRQ)
5.10CNYUpdated Sep 21, 2026
Total Assets
1.05BCNY
157.13M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
742.48MCNYFY2025 · Dec 31, 2025
Total Liabilities
432.93MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
310.55MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
32.75MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
400.18MCNYFY2025 · Dec 31, 2025
Cash
248.28MCNYFY2025 · Dec 31, 2025
Cash Equivalents
856.82KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
249.14MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
707.86KCNYFY2025 · Dec 31, 2025
Accounts Receivable
359.31MCNYFY2025 · Dec 31, 2025
Inventory
84.33MCNYFY2025 · Dec 31, 2025
Accounts Payable
147.44MCNYFY2025 · Dec 31, 2025
Short-term Debt
67.32MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.15MCNYFY2025 · Dec 31, 2025
Long-term Debt
21.34MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
120.00MCNYFY2025 · Dec 31, 2025
Retained Earnings
-119.13MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
620.10MCNY
92.53M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
37.10MCNYFY2025 · Dec 31, 2025
52-Week Low
23.20CNYUpdated Sep 21, 2026
52-Week High
84.96CNYUpdated Sep 21, 2026
52-Week Change
80.39%
vs all stocks
Updated Sep 21, 2026
Beta
0.5000x
vs all stocks
Updated Sep 21, 2026
50-Day MA
61.54CNYUpdated Sep 21, 2026
200-Day MA
54.80CNYUpdated Sep 21, 2026
Avg 10-Day Volume
2.29MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
3.19MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
-0.3600CNYUpdated Sep 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.